The Impact of Type 2 Diabetes in Parkinson's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Impact of Type 2 Diabetes in Parkinson's Disease

Published:2022-06-14 Issue:8 Volume:37 Page:1612-1623
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Athauda Dilan¹²³^ORCID,Evans James¹²,Wernick Anna¹²,Virdi Gurvir¹²,Choi Minee L.¹²,Lawton Michael⁴,Vijiaratnam Nirosen³,Girges Christine³,Ben‐Shlomo Yoav⁴,Ismail Khalida⁵,Morris Huw³,Grosset Donald⁶,Foltynie Thomas³^ORCID,Gandhi Sonia¹²³

Affiliation:

1. Neurodegeneration Biology Laboratory Francis Crick Institute London United Kingdom

2. UCL Queen Square Institute of Neurology London United Kingdom

3. Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London United Kingdom

4. School of Social and Community Medicine University of Bristol Bristol United Kingdom

5. Department of Psychological Medicine King's College London United Kingdom

6. Institute of Neurological Sciences Queen Elizabeth University Hospital Glasgow United Kingdom

Funder

Edmond J. Safra Philanthropic Foundation

Parkinson's UK

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29122

Reference59 articles.

1. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression

3. Association between diabetes and subsequent Parkinson disease

4. Shared dysregulated pathways lead to Parkinson's disease and diabetes

5. Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2024-09-10

2. Pesticides and lifestyle factors are associated with disease severity of Parkinson’s disease: a longitudinal study;2024-09-06

3. Corneal nerve fibre loss as a marker to identify the impact of diabetes on Parkinson's disease;Psychogeriatrics;2024-08-29

4. What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?;Neurology;2024-08-27

5. Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?;Neuropharmacology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3